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Synopsis  
EphB receptors and their ligands are important for tissue boundary formation during development, and 
are also involved in mediating cancer cell invasion. This form of contact-mediated cell-cell repulsion is 
dependent on removal of EphB receptors from the cell surface. Here we investigate the role of clathrin-
mediated endocytosis in EphB2-mediated cell repulsion. We show that it is both clathrin- and Eps15R-
dependent and identify a novel clathrin-binding motif in Eps15R that is important for efficient cell-cell 
repulsion.  
 
 
Graphical abstract 
 
 
  
	   2	  
Abstract 
Expression of Eph receptors and their ligands, the ephrins, have important functions in boundary 
formation and morphogenesis in both adult and embryonic tissue. The EphB receptors and ephrinB 
ligands are transmembrane proteins that are expressed in different cells and their interaction drives cell 
repulsion. For cell repulsion to occur, trans-endocytosis of the inter-cellular receptor-ligand EphB-
ephrinB complex is required. The molecular mechanism underlying trans-endocytosis is poorly defined. 
Here we show that the process is clathrin- and Eps15R-mediated using Co115 colorectal cell lines 
stably expressing EphB2 and ephrinB1. Cell repulsion in co-cultures of EphB2- and ephrinB1-
expressing cells is significantly reduced by knockdown of Eps15R but not Eps15. A novel interaction 
motif in Eps15R, DPFxxLDPF, is shown to bind directly to the clathrin terminal domain in vitro. 
Moreover, the interaction between Eps15R and clathrin is required for EphB2-mediated cell repulsion as 
shown in a rescue experiment in the EphB2 co-culture assay where wild type Eps15R but not the 
clathrin-binding mutant rescues cell repulsion. These results provide the first evidence that Eps15R 
together with clathrin control EphB/ephrinB trans-endocytosis and thereby cell repulsion. 
 
 
Introduction 
EphB receptors are a large family of receptor 
tyrosine kinases that interact with the 
transmembrane ephrinB ligands. EphB/ephrinB 
signalling is important for contact-mediated cell 
repulsion and tissue patterning during 
development, but also in adult tissue to 
establish morphological borders in the intestine 
or to direct growing axons in the nervous 
system1-3. Furthermore, aberrant expression or 
mistargeted expression of Eph receptors is 
associated with cancer cell invasion in prostate, 
breast and colon cancer4-9. The adhesive 
interaction between EphB receptors and 
ephrinB ligands activates intracellular signalling 
pathways that regulate cell-cell repulsion, 
migratory behaviour, adhesion and cell polarity. 
The EphB receptor and the ephrinB ligands are 
not expressed in the same cell and their 
interaction can therefore lead to cell-cell 
repulsion. However, in order for the cells to 
repel the EphB/ephrinB complex needs to be 
physically removed or to dissociate. There are 
two mechanisms described to date: trans-
endocytosis (trans-cellular internalisation 
event) of the receptor-ligand complex into one 
of the cells10,11, or cleavage of the extracellular 
domain by a protease12-15. The endocytosis of 
EphB/ephrinB complexes is an unusual type of 
endocytosis where two trans-membrane 
proteins from neighbouring cells are 
internalised into one cell, thus forming vesicles 
from two plasma membranes11. The process, 
called trans-endocytosis, is dependent on 
dynamin scission and actin polymerisation but 
no association with either clathrin or caveolae 
has been found10,11,16,17. Thus, the molecular 
mechanism requires further investigation.  
 
The EphB2 receptor interacts with the 
endocytic adaptor protein Numb 18. Numb is a 
phosphotyrosine binding adaptor protein that 
regulates receptor trafficking19. Numb interacts 
directly with the endocytic adaptor protein AP2 
and endocytic accessory proteins Eps15/R and 
intersectin1/2 20-22. AP2 is the main adaptor 
protein that directs the clathrin coat formation23. 
The interaction of Numb with AP2 is mediated 
by a single DPF (aspartic acid, proline, 
phenylalanine) motif, an interaction that is too 
weak to functionally engage the AP2 complex 
and actively promote clathrin-mediated 
endocytosis 22-24, suggesting that the 
recruitment of endocytic accessory proteins is 
important for Numb-mediated EphB2 receptor 
endocytosis.  
 
In this study, we identified novel components of 
the trans-endocytosis pathway for 
EphB/ephrinB internalisation. Here we co-
cultured colorectal cancer cell-lines, Co115, 
stably expressing the full-length 
transmembrane EphB2 receptors or ephrinB1 
ligands. Using the co-culture system, we found 
that EphB2-mediated cell-cell repulsion is a 
clathrin- and dynamin-dependent mechanism. 
Moreover we identified a key component in the 
trans-endocytosis protein complex, Eps15R, 
that interacts with EphB2 via the adaptor 
protein Numb. Using shRNA knockdowns, 
morphological analysis, and motif mapping, we 
identified a novel non-canonical clathrin-binding 
motif in Eps15R that was functionally important 
for EphB2-mediated cell-cell repulsion. These 
results suggest that Eps15R and clathrin-
mediated trans-endocytosis of the 
EphB2/ephrinB1 complex is an important 
mechanism for terminating this adhesive 
interaction and turning it into cell-cell repulsion.  
 
Results 
EphB2-mediated cell repulsion is regulated by 
clathrin-mediated endocytosis 
To visualise EphB2-mediated cell repulsion we 
used the colorectal cancer cell line Co115 
stably expressing EphB2 and EGFP, ephrinB1 
and RFP, EGFP alone and RFP alone5. The 
cells were co-cultured for 48h, fixed, imaged 
and the size of the clusters of EGFP-
expressing cells was quantified as previously 
described5. During the co-culture the initially 
randomly mixed EphB2- and ephrinB1-
expressing cells repelled over time to minimise 
contact and formed homogenous clusters 
(groups) of cells expressing either EphB2 
receptor or ephrinB1 ligand, resulting in a 
pattern formation of the two cell lines, which is 
distinct from the co-culture of EphB2-
expressing cells with RFP or two cell lines that 
do not express EphB receptor or ligand (Fig. 
1A). Quantification of the percentage of 
clusters of EGFP-positive cells showed that 
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EphB2-expressing cells formed large clusters 
when co-cultured with ephrinB1-expressing 
cells (Fig. 1B), but were more mixed (a higher 
proportion of small EGFP-positive cell clusters) 
when co-cultured with control RFP-expressing 
cells consistent with previous observations5. 
Cell clusters containing >31 cells were not 
present in control co-cultures (Fig. 1B). As the 
ephrins are involved in tissue patterning, we 
applied an established method for pattern 
analysis on our EphB-mediated cell repulsion 
assay that has been developed for analysing 
chimeric patterning in retina tissues25,26. This 
method has been shown to distinguish between 
random mixing and clustered patterns formed 
by two cell populations both in tissue and in 
computer models26. It has the advantage of 
correcting for unequal proportions of the two 
populations that may arise at the seeding stage 
of the repulsion assay in the ‘pattern score’ that 
is generated25. The images collected from our 
assay showed striking differences in patterning 
(Fig. 1A). The results showed that the method 
reliably discriminates between cell clustering in 
EphB/ephrinB co-culture and the random cell 
mixing in the two controls where RFP-
expressing cells were co-cultured with either 
EphB2- or EGFP-expressing Co115 cells (Fig. 
1C; p<0.0001, Student’s t-test). Thus, we 
conclude that image analysis of patterning can 
be applied to EphB-ephrinB cell repulsion 
studies as we found it to produce reproducible 
data in agreement with previously published 
findings5.  
 
To analyse whether EphB2-mediated cell 
repulsion was dependent on the GTPase 
dynamin-1, a scission molecule that is involved 
in most endocytic pathways to sever 
membrane buds from the plasma membrane, 
we overexpressed the dominant negative 
GTPase mutant T65A in our co-cultures27. 
Inhibition of dynamin-mediated membrane 
scission strongly reduced the clustering of 
EphB receptor and ephrinB1 expressing cells 
(Fig. 1D-F; p<0.0001). Because multiple 
endocytic pathways are dependent on 
dynamin-1 for membrane scission we next 
used a specific reagent to block clathrin-
mediated endocytosis, AP180 C-terminus. 
AP180 is a membrane-binding protein that 
promotes clathrin polymerisation and formation 
of endocytic membrane buds28,29. The C-
terminus of AP180 has multiple clathrin-binding 
motifs and overexpression of this domain 
efficiently blocks internalisation of receptors 
that are internalised via clathrin-mediated 
endocytosis29-31. Expression of AP180 C-
terminus in the Co115 co-cultures with EphB2 
(GFP) and ephrinB1 (RFP) inhibited 
EphB/ephrinB cell patterning and increased cell 
mixing (Fig. 1D, F; p<0.0001), thus establishing 
that EphB2-mediated cell repulsion is regulated 
by clathrin-mediated endocytosis. 
 
EphB2 interacts with Eps15R and Eps15 via 
Numb 
To further our understanding of EphB2 trans-
endocytosis we next sought to identify novel 
components of the endocytic complex. Studies 
using immuno-precipitation and mass 
spectrometry methods to map the interactome 
of EphB2 have not yielded data that identify 
endocytic proteins32,33. We therefore decided to 
target our search to the previously identified 
endocytic adaptor protein of EphB2, Numb18. 
The interaction between Numb and EphB2 is 
mediated by the phosphotyrosine-binding 
(PTB) domain of Numb, and is functionally 
important during neural development18. Numb 
has previously been implicated in receptor-
mediated endocytosis, particularly of receptor 
tyrosine kinases19. It is comprised of a PTB 
domain that binds to activated receptor tyrosine 
kinases, a motif domain containing proline-rich 
motifs binding SH3 domains, a single DPF 
motif that binds the clathrin adaptor AP2, and 
two NPF motifs that bind EH-domain containing 
proteins18,22,34,35. AP2 is the major adaptor 
protein for bringing in cargo to clathrin-coated 
pits. However the weak affinity interaction of a 
single DPF motif binding to AP2 (Kd≈1µM) is 
not sufficient for formation of a stable protein 
complex that can nucleate clathrin coat 
formation24,36. We therefore performed a small 
interaction screen of EH domain-containing 
endocytic proteins to identify interaction 
partners of the NPF motifs in Numb. The NPF 
motif binds EH domains and there are a 
number of endocytic scaffold proteins that 
contain multiple EH domains; Eps15, Eps15R, 
intersectin-1, intersectin-2. EH domain scaffold 
proteins serve important functions in clathrin-
mediated endocytosis, in particular by 
facilitating the formation of multi-protein 
complexes37-39. To investigate which endocytic 
EH-domain containing proteins interacted with 
Numb, a screen was performed with EH 
domains of Eps15R, Eps15, intersectin-1, and 
intersectin-2 expressed as recombinant GST-
tagged protein and immobilised on beads. We 
found that Numb specifically bound the second 
EH domains of Eps15R and Eps15, but not the 
EH domains of intersectin-1 or -2 (Fig 2A). 
Thus, Numb has a binding specificity for certain 
EH domains. We found that Eps15R and 
Eps15 both form a complex with EphB2 in vivo 
together with Numb, as shown in a co-
immunoprecipitation assay from HEK293T cells 
(Fig. 2B). The interaction was more prominent 
upon stimulation of the EphB2-expressing cells 
with pre-clustered extracellular domain of 
ephrinB1. A kinase dead mutant of EphB2 was 
used as a control for ligand activation. We 
suggest that this protein complex consisting of 
EphB2-Numb-Eps15/R could function as the 
adaptor complex for EphB2 endocytosis 
mediated by clathrin, which has not been 
described previously. We therefore pursued 
further study of the role of Eps15R and Eps15 
in the endocytosis of EphB2 receptor. 
 
The role of Eps15R and Eps15 in clathrin-
mediated endocytosis 
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Having established that trans-endocytosis is 
clathrin-mediated and that the EphB2 receptor 
forms a complex with Eps15R and Eps15, we 
next wanted to explore the molecular 
mechanisms further. Eps15 and Eps15R have 
been suggested to not have a significant role in 
clathrin-mediated endocytosis based on 
receptor uptake studies as only small inhibitory 
effects on EGFR and transferrin uptake are 
observed when it is knocked down37,40. 
However, acute perturbation of Eps15R 
interactions by microinjection of antibodies into 
cells shows a profound inhibition of endocytosis 
of EGF, suggesting that it has an important role 
in endocytosis of EGFR21.  
To study the kinetics of clathrin-coated pit 
formation we used live cell imaging of BSC1 
cells stably expressing AP2-σ2-EGFP (Fig. 3A-
B). These cells lend themselves to live cell 
imaging due to their large size and flat shape. 
Cells were treated with shRNA against 
Eps15R, Eps15 or Eps15R+Eps15 and the 
lifetime of AP2-σ2-EGFP was quantified (Fig. 
3A-C). In Eps15R knockdown cells the AP2 
punctae had a significantly longer lifetime (42 
s) compared to cells treated with control 
shRNA (shCTRL, 27 s), reflecting a slowing of 
clathrin-coated pit maturation (Fig. 3B). 
Knockdown of Eps15 did not have a significant 
effect compared to control (26 s), and 
knockdown of both Eps15R and Eps15 did not 
show an additional increase in lifetime 
compared to knockdown of Eps15R alone (Fig. 
3A-B). Western blot analysis of BSC1 cell 
lysates showed an efficient knockdown of 
Eps15R or Eps15 protein levels, and did not 
show a compensatory increase in either Eps15 
or Eps15R expression (Fig. 3C). This 
suggested that Eps15R and Eps15 are 
functionally diverse and we therefore focused 
further experiments on Eps15R. 
Knockdown of Eps15R showed a reduced 
uptake of fluorescent transferrin in both HeLa 
and BSC1 cells treated with shRNA targeting 
the EPS15R gene (shEPS15R; Fig. 3D) 
demonstrating that clathrin-mediated 
endocytosis was significantly inhibited when 
Eps15R was depleted. We analysed a large 
number of cells by FACS (fluorescence 
activated cell sorting), which may explain why a 
significant difference in transferrin uptake was 
observed contrary to previous studies where 
smaller sample sizes have been analysed37,40. 
Furthermore, using confocal microscopy we 
observed a significant reduction in the density 
of clathrin-coated pits (CCPs), on the plasma 
membrane of HeLa cells where Eps15R had 
been knocked down (Fig. 3E-G). To investigate 
whether the knockdown of Eps15R changed 
the size or shape of CCPs, high-resolution 
images were collected using transmission 
electron microscopy. Morphometric analysis 
showed an increase in the mean diameter of 
CCPs and vesicles (Fig. 3H, I; 124 nm versus 
143 nm). In addition, an increase in the 
proportion of open versus closed CCPs was 
observed in the Eps15R deficient cells (42% 
versus 24%). A quantification of the width of 
the open neck of coated pits of all different 
stages of invagination was performed which 
provided a measure of clathrin-coated vesicle 
closure. A significant increase in the average 
diameter of the neck of the clathrin-coated 
membrane buds in Eps15R knockdown cells 
was observed, shown here in electron 
micrographs and histograms of the frequency 
distribution of neck diameters (Fig 3H, J). 
Focusing in on the diameter of necks of 10-
100nm clearly illustrated the differences 
between control and Eps15R knockdown cells 
(Fig. 3K). While control clathrin-coated 
intermediates had a median neck diameter of 
26 nm the intermediates from Eps15R deficient 
cells had a median neck diameter of 54 nm 
(Fig. 3L). A similar phenotype was previously 
observed when proteins that regulate clathrin 
assembly; amphiphysin-1, CALM or NECAP-1, 
were knocked down or functionally perturbed41-
44. The phenotype that we describe here for 
Eps15R depletion; slowing of CCP maturation, 
reduced transferrin receptor uptake, and 
aberrant clathrin coat formation; thus point 
towards a functional role for Eps15R in 
regulation of clathrin coat assembly. 
 
Eps15R formed a direct interaction with clathrin 
heavy chain terminal domain  
The prominent effect on clathrin-coat 
morphology following Eps15R knockdown led 
us to next examine whether Eps15R interacted 
directly with clathrin. Clathrin showed a 
stronger association with EGFP-Eps15R 
compared to EGFP-Eps15 in a co-
immunoprecipitation assay from HeLa cell 
extracts (Fig. 4A). No clathrin was co-
immunoprecipitated by control EGFP. AP2 was 
used as a control and was co-
immunoprecipitated by both EGFP-Eps15R 
and EGFP-Eps15. Thus, Eps15R can bind both 
clathrin and AP2 in vivo. We next mapped the 
region responsible for clathrin-binding using C-
terminally truncated constructs of EGFP-
Eps15R. Deletion of the ubiquitin interacting 
motif (UIM) domains (leaving aa 1-861) or 
UIMs plus the proline-rich region (leaving aa 1-
747) did not impact on clathrin co-
immunoprecipitation, whereas a construct (aa 
1-596) additionally lacking the motif domain lost 
both clathrin and AP2 binding (Fig. 4B). To 
further narrow down the clathrin-binding site we 
used GST-tagged constructs comprising the 
motif domain and truncations thereof in a pull-
down assay. The shortest construct that bound 
clathrin from HeLa cell extract was aa 717-729 
(Fig. 4C). However, it should be noted that a 
slightly longer construct (aa 699-729) bound 
clathrin more efficiently (Fig. 4C). To identify a 
clathrin-binding motif in Eps15R, we used the 
shortest construct identified in figure 4C and 
mutated individual amino acids (aa 718-728) to 
alanine residues. These mutated peptides were 
used in a GST pull-down assay. Our affinity 
purification assay using multiple peptides with 
alanine substitutions identified a binding motif 
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between Eps15R and clathrin, DPFxxLDPF 
(Fig. 4D). An alignment of Eps15R orthologues 
showed that the DPFxxLDPF motif was 
conserved across vertebrates, and highlighted 
an additional LDPF motif starting at amino acid 
700 that is only present in placental mammals 
(Fig. 4E, Fig. S1). In comparison, Eps15 does 
not contain any LDPF motifs. Pair-wise 
sequence alignment of Eps15R aa 699-729 
with the corresponding DPF-containing region 
of Eps15 (aa 687-723) only showed a 14.6% 
identity. We compared the binding of clathrin to 
this region of Eps15R and Eps15 in a GST pull-
down, and found that Eps15R but not Eps15 
associated with clathrin (Fig. 4F). Next we 
investigated the significance of having two 
LDPF motifs in tandem in the Eps15R 
sequence. The first LDPF sequence (aa 699-
709) did not show significant binding to clathrin 
on its own (Fig. 4C). We investigated whether 
this additional LDPF motif could explain the 
increased binding efficiency of Eps15R aa 699-
729 compared to aa 717-729 (Fig. 4C). Indeed, 
mutation of F703A, F722A, or F728A in a 
longer Eps15R peptide (aa 699-729) reduced 
clathrin binding (Fig. 4G). The LDPF motif is a 
non-canonical clathrin motif, similar to the 
classic clathrin boxes DLL, LLxLD and PWDxW 
that contain hydrophobic residues and interact 
with clathrin heavy chain terminal domain 45-48. 
Finally, to investigate whether the DPF motif 
that is conserved between the two LDPF motifs 
would also contribute to clathrin binding we 
compared two mutants, D707A and F709A 
from this DPF motif, to wild type Eps15R and 
found that F709A but not D707A reduced 
clathrin binding (Fig. 4H). In summary, having 
two LDPF motifs in tandem in Eps15R 
increased the binding efficiency of clathrin and 
the addition of a DPF motif two amino acids 
upstream of a LDPF motif also increased the 
clathrin association with Eps15R. To 
investigate which region of clathrin heavy chain 
Eps15R interacted with, we performed a pull-
down assay with purified domains of clathrin 
and recombinant full-length Eps15R. Only the 
N-terminal domain of clathrin bound Eps15R 
efficiently (Fig. 4I). We concluded that Eps15R 
associated directly with the clathrin terminal 
domain via a non-canonical motif, DPFxxLDPF. 
 
Overexpression of single Eps15R mutants 
F703, F722, F728 in the clathrin-binding motif 
are not critical for the subcellular localisation of 
clathrin 
To investigate whether the DPFxxLDPF motif in 
Eps15R directs the localisation of clathrin, we 
transiently overexpressed Eps15R containing a 
wild type clathrin-motif or alanine mutants of 
residues 703, 722 or 728. The co-localisation 
with clathrin in HeLa cells was examined using 
confocal microscopy. All three single mutants 
showed a punctate pattern that co-localised 
with clathrin at the plasma membrane (Figure 
S2A-D). Quantification of the size of the 
punctae did not show a significant difference to 
wild type Eps15R (Fig. S2E). These results 
suggest that in the context of full-length 
Eps15R individual mutations in the identified 
clathrin-binding motif do not reduce the affinity 
for clathrin enough to affect recruitment of 
clathrin to the plasma membrane, and we 
therefore pursued experiments using a triple 
alanine mutation comprising the three 
phenylalanines, F703A/F722A/F728A.  
 
Eps15R regulates AP2-clathrin complex 
formation in vitro and in vivo 
To investigate whether the Eps15R 
F703A/F722A/F728A triple mutant (Eps15R 
mut) associated less readily with clathrin we 
performed a co-immmunoprecipitaiton assay. 
Immunoprecipitation of the mutant Eps15R 
(EGFP-Eps15Rmut) from cell lysates showed 
that less clathrin was co-precipitated compared 
to the wild-type protein (Fig. 5A). Quantification 
of the clathrin immunoblots from three 
independent experiments showed a halving of 
the amount of clathrin that was co-
immunoprecipitated with Eps15Rmut compared 
to wild type protein (Fig. 5B). The amount of 
AP2 that co-immunoprecipitated with 
Eps15Rmut was also reduced, and we 
hypothesise that it was likely to be due to the 
reduced amount of clathrin that was 
accumulated since the high-affinity AP2-binding 
site (FxxF) in Eps15R was not compromised. 
To examine whether Eps15R may strengthen 
clathrin-AP2 interactions by providing an 
expanded binding platform for these proteins, 
we examined the effect on clathrin-binding to 
AP2-β2-appendage with its hinge (aa 616-937) 
in lysates from cells over-expressing wild type 
and mutant Eps15R (Fig. 5C). AP2 functions as 
an important adaptor for clathrin and it contains 
clathrin-binding motifs in its β2 hinge, and is 
known to be a key factor in regulating clathrin 
polymerisation23,36,49. To investigate the 
contribution of Eps15R to the clathrin-AP2 
interaction and how efficiently the AP2-clathrin 
complex forms in the presence or absence of 
Eps15R we performed GST pull-downs with 
AP2 β2-hinge containing the clathrin-binding 
motif. Western blot analysis of the pull-down 
experiments indicated that a strong reduction of 
clathrin association with AP2-β2-appendage-
hinge occurred in samples where mutant 
Eps15R was over-expressed (Fig. 5C-D). 
Similar amounts of wild type and mutant 
Eps15R were bound to AP2-β2-appendage-
hinge and the expression of clathrin in the two 
cell extracts was similar (Fig. 5C, D). Thus, 
these experiments suggest that Eps15R 
regulates clathrin-AP2 interactions. The 
clathrin-AP2 interaction has been suggested to 
be the dominant mechanism that controls 
clathrin coat assembly23, and we hypothesise 
that Eps15R adds an additional layer of 
regulation to this mechanism.  
 
Expression of the triple mutant EGFP-Eps15R 
(F703, F722, F728) in HeLa cells showed that it 
still targeted to the plasma membrane and co-
localised with clathrin and AP2 (Fig. 5E-F). 
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Thus, mutation of the LFPF motifs did not 
perturb the trafficking of Eps15R, and 
suggested that Eps15R is not recruited to 
clathrin-coated pits by clathrin. This is not 
surprising based on the literature available 
describing the high avidity protein interactions 
for Eps15, AP2 and clathrin and furthermore 
the potential for heterodimerization between 
Eps15R and Eps1523,36. However, we did 
notice that our mutant Eps15R formed 
expanded punctae compared to wild type 
Eps15R (Fig. 5E-G), implying that it does have 
an impact on clathrin coat formation. Based on 
our biochemistry data we suggest that this is 
due to regulation of clathrin-AP2 interactions. 
Taken together these results suggest that 
Eps15R is not directly recruited by clathrin, but 
can regulate the maturation of clathrin-coated 
pits together with clathrin adaptor proteins such 
as AP2. 
 
The Eps15R-clathrin interaction is necessary 
for EphB2-mediated cell-cell repulsion 
Finally, we wanted to examine the significance 
of the Eps15R-clathrin interaction in trans-
endocytosis of EphB/ephrinB complexes. We 
again used the Co115 co-culture assay. First, 
we stably knocked down Eps15R in EphB2-
expressing cells and co-cultured them with 
ephrinB1-expressing cells or control RFP-
expressing cells (Fig. 6A-B). We quantified the 
cell pattern score as before, and showed that 
treatment with Eps15R shRNA resulted in a 
significant reduction in EphB2-mediated 
patterning (Fig. 6A, B). However, it should be 
noted that we did not observe a complete 
inhibition of cell-cell repulsion as the cells are 
not mixed to the same extent as the controls 
(Fig. 6A, B). These observations are in 
agreement with the slowing rather than 
complete inhibition of clathrin-mediated 
endocytosis that we demonstrated earlier by 
live cell imaging of CCPs (Fig. 3A, B). 
Knockdown of Eps15 did not significantly alter 
the patterning compared to the control (Fig. 6A, 
B). 
Finally, we performed a rescue experiment to 
restore trans-endocytosis of the EphB2-
ephrinB1 complex, and cell-cell repulsion, in 
Eps15R knockdown cells (shEPS15R) by re-
expression of wild type or mutant Eps15R 
(F703A/F722A/F728A). The trans-endocytosis, 
and hence the repulsion and EphB2-mediated 
patterning, was restored to normal by 
expression of wild type Eps15R but not by the 
clathrin-binding mutant Eps15Rmut (Fig. 6C, 
D), demonstrating the functional importance of 
the Eps15R-clathrin interaction. As a control, 
we overexpressed full-length Eps15 and 
showed that it cannot compensate for the loss 
of Eps15R (Fig. 6C, D). Importantly, this 
demonstrated that Eps15R has a distinct 
function that is not redundant in Eps15. Taken 
together these results show that the interaction 
between Eps15R and clathrin is critically 
important to maintain functional endocytosis of 
the EphB2-ephrinB1 complex resulting in cell-
cell repulsion in cell culture.  
 
Discussion 
Contact-mediated cell repulsion mediated by 
EphB-ephrinB interactions is important during 
development, synaptic plasticity, and in cancer 
progression1,50,51. In order to understand how 
the EphB-ephrinB complex is trans-
endocytosed, identification of novel interactions 
with endocytic proteins that are bound to the 
complex is necessary, as this is a poorly 
defined mechanism. Studies using proteomics 
approaches to identify novel interaction 
partners of the EphB2 receptor have not yet 
identified proteins involved in receptor 
trafficking32,33. In this study we therefore 
instead used a targeted approach and 
employed the EphB2 interaction partner 
Numb18 as a starting point to show that it 
directly interacted with endocytic proteins 
Eps15 and Eps15R. This protein complex, 
EphB2/Numb/Eps15/Eps15R, formed upon 
receptor-stimulation with soluble ephrinB1 
ligand. Here we report the interaction of 
endocytic protein Eps15R with the EphB2 
receptor and how its interaction with clathrin 
was required to facilitate trans-endocytosis. 
Specific perturbation of clathrin-mediated 
endocytosis by overexpressing AP180 C-
terminus provided the first evidence that EphB2 
trans-endocytosis is clathrin-dependent.  
Knocking down expression of Eps15R, but not 
Eps15, reduced EphB2-mediated cell repulsion 
and thus demonstrated the significance of this 
endocytic accessory protein in trans-
endocytosis and furthermore showed that 
Eps15R and Eps15 are not functionally 
redundant in this context.  
 
Clathrin-mediated and non-clathrin-mediated 
endocytosis pathways are important for 
internalisation of different cargos under 
different conditions52,53. Trans-endocytosis of 
EphB receptors and ephrinB ligands is known 
to be actin dependent10,11,16. In general, the 
actin cytoskeleton is involved in internalisation 
of larger endocytic intermediates such as 
macropinocytosis, phagocytosis and bacterial 
internalisation but is generally not associated 
with clathrin-mediated endocytosis53,54. 
Because the EphB/ephrinB endocytic 
membrane invaginations are large assemblies 
containing plasma membranes from two 
neighbouring cells the requirement of force 
generated by the actin cytoskeleton could be 
compared to cells under high membrane 
tension or with a polarised membrane where 
clathrin-mediated receptor endocytosis is actin-
dependent55,56. It was recently shown that the 
mechanism of internalisation for soluble 
ephrinB1 ligand is different to that of membrane 
bound ligand16, which may explain the 
discrepancy between our results and data from 
other groups suggesting that trans-endocytosis 
is actin-dependent but clathrin-
independent10,11. In our experiments we used 
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co-cultures of cells expressing full-length 
EphB2 and ephrinB1. Moreover previous 
studies only assessed co-localisation of clathrin 
with EphB and ephrinB rather than perturbing 
clathrin interactions. We suggest that EphB 
trans-endocytosis is both actin- and clathrin-
dependent. 
 
We identified a novel interaction between 
Eps15R and clathrin and showed that it is 
functionally important for EphB2 trans-
endocytosis in our rescue experiments. This 
interaction is mediated by a non-canonical 
clathrin-binding motif that binds to the terminal 
domain of clathrin heavy chain. We showed 
that this motif, DPFxxLDPF, binds better when 
arranged in tandem with an additional LDPF 
motif. Eps15R is the only human protein with 
two LDPF motifs in tandem, but there are a 
number of proteins that contain a PF-(x)n-LDPF 
motif. One example is BMP2K, a kinase that 
associates with clathrin-coated vesicles and co-
immunoprecipitates with Numb but as of yet 
does not have a defined function in clathrin-
mediated endocytosis35,57. The data presented 
in this paper suggests a potential direct 
association between BMP2K and clathrin via 
this non-canonical clathrin motif described in 
this paper. Peptides containing DPF motifs 
have been previously shown to bind to the 
clathrin terminal domain and AP2 with dual 
specificity58. The 725LDPF in Eps15R is slightly 
different in that when mutated it loses clathrin 
binding more readily than AP2 association, 
which is an interesting observation. It is 
established that the spacing of DPF motifs is 
critical for determining binding specificity for 
both FCHo2 and AP224,59. How this motif 
spacing is deciphered and decoded by the 
interaction partner is not known. In light of 
these studies, the differences between Eps15 
versus Eps15R in terms of number of DPF 
motifs (13 compared to 16), the overall low 
amino acid conservation of the motif domains 
(25% identity) and the difference in spacing of 
the DPF motifs are likely to reflect functional 
differences. Here we show that clathrin 
associates more strongly with Eps15R 
compared to Eps15 and that the two clathrin-
binding LDPF motifs identified in Eps15R are 
not present in Eps15. Future research on the 
functional role of motif spacing in endocytic 
proteins will be important to further our 
understanding of the process. 
 
Our study uncovers a novel link between 
Eps15R and clathrin that is functionally 
important. We hypothesise that Eps15R via its 
binding to clathrin may regulate clathrin coat 
assembly through formation of a stronger 
clathrin-AP2 complex and a more stable coat, 
which is supported by our observation that 
knockdown of Eps15R increases pit size and 
reduces pit number. In our morphological 
analysis of Eps15R knockdown cells we 
discovered that Eps15R regulates the shape 
and size of clathrin-coated pits, with a distinct 
increase in the width of the neck of the CCPs. 
Similar morphological phenotypes have been 
reported previously when clathrin-binding 
proteins NECAP1 and CALM have been 
depleted42,44. The mechanism for how Eps15R 
would regulate clathrin assembly is not clear 
from our data, and would require further 
experiments. However, it is feasible that 
Eps15R acts as a molecular brace for clathrin 
at the rim of clathrin-coated pits. Eps15R and 
Eps15 have a central coiled-coil region that 
mediates anti-parallel dimerization60, which 
would position the clathrin motifs on opposite 
sides of an 18 nm rigid coiled-coil. The distance 
between the vertices where the clathrin 
terminal domains are located in a spherical 
clathrin coat is 18.6 nm61. Eps15R could thus 
cross-link terminal domains at a distance that 
would favour formation of a spherical clathrin 
cage. 
 
In summary, we report that Eps15R and 
clathrin regulate EphB2-mediated cell repulsion 
through trans-endocytosis. Future studies are 
required to identify additional components 
involved in EphB2-mediated trans-endocytosis 
and the role of the clathrin and clathrin-adaptor 
proteins such as Eps15R in cellular processes 
that are EphB-mediated during development 
and in disease.   
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Materials and Methods 
Antibodies 
Antibodies used in this study for 
immunofluorescence staining include: clathrin 
heavy chain mouse monoclonal (clone X22, 
1:250 dilution), AP2 α-adaptin mouse 
monoclonal (clone AP6, AbCam ab2730, 1:200 
dilution), clathrin heavy chain rabbit polyclonal 
(AbCam, ab21679, 1:1500 dilution), Eps15R 
rabbit polyclonal (AbCam, ab53006, 1:200 
dilution), FCHo2 rabbit polyclonal (Ra103; aa 
525-890, 1:200 dilution31), Eps15 rabbit 
polyclonal (Ra15, aa 530-791; 1:500 dilution62). 
Goat anti-mouse and anti-rabbit Alexa-488, -
546 and -647 conjugated secondary antibodies 
were used at 1:500 dilution (Life Technologies). 
For immunoblotting the following antibodies 
were used: clathrin heavy chain (BD 
Transduction Laboratories, #610500, 1:10,000 
dilution), AP2-β-adaptin (clone 100/1, Sigma, 
A4450, 1:5,000 dilution), EGFP (AbCam, 
ab290, 1:20,000 dilution), Flag (clone M2, 
Sigma, F3165, 1:2,000 dilution), His (GE 
Healthcare, #27-4710-01, 1:1,000 dilution), β-
actin (AbCam, ab6276, 1:10,000 dilution), 
Eps15 (Santa Cruz, C-20, 1:2000 dilution). 
 
Plasmids 
Rat AP2-β appendage+hinge (aa 616-937) was 
cloned into pGEX4T2. Mouse Eps15R motif 
domain constructs and mutants thereof were 
cloned in pGEX6p3 as follows: aa 558-748; aa 
701-747; aa 699-729; aa 699-709; aa 717-729. 
Human Eps15 motif domain aa 687-723 was 
cloned in pGEX6p3. Human clathrin heavy 
chain domains; aa 2-579, aa 438-1073, aa 
1073-1675; were cloned in pGEX6p2. EH 
domains were cloned in pGEX6p3; Eps15 EH1 
(aa 9-103), Eps15 EH2 (aa 121-215), Eps15 
EH3 (aa 217-313), intersectin-1 EH1 (aa 14-
108), intersectin-1 EH2 (aa 214-309), 
intersectin-2 EH1 (aa 14-108), intersectin-2 
EH2 (aa 236-331), Eps15R EH1 (aa 8-104), 
Eps15R EH2 (aa 254-362), Eps15R EH3 (aa 
381-564). C-terminally truncated mouse 
Eps15R cloned in pEGFP-C1 was kindly 
provided by Dr. A. Benmerah; aa 1-907 (full-
length), aa 1-861 (∆UIM), aa 1-747 (∆ proline-
rich region), aa 1-596 (∆ motif domain). Full-
length human Eps15 was cloned in pCi-N-
EGFP or pCi-N-myc. Full-length human Numb 
was cloned in pEGFP-C3. Full-length shRNA-
resistant mouse Eps15R was cloned in pCi-N-
EGFP or pCi-N-myc. Control shRNA from 
Sigma MISSION 
(CAACAAGATGAAGAGCACCAA), shEPS15 
(GTTTGGGAGTTGAGTGATA) and shEPS15R 
(GTAAAGGGTTCTTGGACAA) were cloned 
into the pLKO1-puro vector. Bovine dynamin1-
T65A was cloned in pCi-N-TagBFP and rat 
AP180-C-terminus (aa 530-915) was cloned 
with a N-terminal tag in pTagBFP-C3. 
 
Protein expression and purification 
GST-tagged proteins were expressed in E. Coli 
BL21 cultured in terrific broth media at 37°C for 
2h following induction with 0.15mM IPTG at 
OD600 0.5-0.7. The bacteria were harvested 
and lysed with a high-pressure homogeniser 
(Constant Systems) in 50mM HEPES pH 7.4, 
500mM NaCl, 2mM DTT. The lysate was 
cleared by centrifugation in a Beckman Ti45 
rotor at 30,000 rpm for 25 min at 4°C. The 
supernatant was incubated with glutathione 
sepharose (GE Healthcare) for 10min, spun 
down, washed extensively, and the beads were 
finally resuspended in 20mM HEPES pH 7.4, 
150mM NaCl and 0.5mM TCEP and used in 
pull-down experiments. 
 
Immunoprecipitations and GST pull-downs 
HeLa cells were homogenised in a lysis buffer 
containing: 20mM HEPES pH 7.4, 100mM 
NaCl, 0.5mM TCEP, 0.1% (w/v) NP-40, 
protease inhibitor cocktail set III (Calbiochem). 
For immunoprecipitates antibodies were added 
to the cleared lysate, incubated on a rotating 
wheel for 3.5h at 4°C, protein A sepharose was 
added and the samples incubated for a further 
0.5h before they were washed extensively with 
the lysis buffer and eluted with sample buffer. 
The immunoprecipitates were analysed by 
immunoblotting. EphB2-expressing cells were 
stimulated with 1µg/ml pre-clustered ephrinB1-
Fc (R&D Systems) for 20 min at 37°C prior to 
lysis and immunoprecipitation. For GST pull-
downs 100-200µg of lysate was added to GST-
tagged protein immobilised on beads and 
incubated for 30-60min at 4°C on a rotating 
wheel. The beads were pelleted and washed 
with lysis buffer multiple times. Bound protein 
was analysed by SDS-PAGE and 
immunoblotting. 
 
Cell Culture 
HeLa, BSC1 σ2-EGFP, and Co115 cells were 
cultured at 37°C and 5% CO2 in Dulbecco’s 
modified Eagle’s medium (DMEM) 
supplemented with 10% (v/v) fetal bovine 
serum. HeLa cells were purchased from the 
European Collection of Cell Cultures. BSC1 σ2-
EGFP cells63 were kindly provided by Dr. 
Kirchhausen (Harvard Medical School, USA). 
Co115 EGFP, Co115 RFP, Co115 
EGFP:EphB2, and Co115 RFP:ephrinB1 cells5 
were kindly provided by Dr. Batlle (Institute for 
Research in Biomedicine, Barcelona, Spain). 
All cell lines were tested for mycoplasma. 
Co115 cell lines in co-cultures were plated at a 
density of 1.5-2.0 x 105 cells per cover slip and 
cultured for 2-3 days in DMEM supplemented 
with 10% fetal bovine serum. In overexpression 
experiments cells were transfected with 1µg/ml 
polyethylenimine (Sigma, #408727) 4-8 hours 
after plating when cells were at 50-80% 
confluency. For knockdown experiments the 
pLKO1-puro vector was used to generate 
lentivirus, which was then applied to the cell 
cultures. After 48h the cell lines were treated 
with puromycin for selection (HeLa 5µg/ml, 
BSC1 σ2-EGFP 10µg/ml, Co115 1µg/ml). The 
knockdown was confirmed by immunoblotting. 
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Epifluorescence, confocal microscopy and 
live cell imaging 
Co-cultures of Co115 cells were imaged on a 
Leica DM5500B epifluorescence microscope 
with a 10x/0.30 HCX PL Fluostar objective. 
Fixed samples were imaged on a Zeiss 780 
confocal microscope equipped with a 63x 
(1.4NA) and a 10x objective.  Images within an 
experiment were collected using fixed laser 
settings and exposure times. Images were 
analysed using ImageJ software (National 
Institutes of Health), and the ClonalTools 
macro was used for pattern analysis as 
described previously25,26. For pattern analysis 
each image was analysed by randomly 
applying perpendicular lines to the image and 
the corrected patch width along the lines was 
quantified. The analysis of percentage of 
EGFP-positive cells was performed as in 
Cortina et al.5. In brief, the number of EGFP-
expressing cells growing in defined groups 
without mixing with RFP-expressing cells were 
quantified in randomly selected areas of 
images and expressed as percentage of the 
total number of cells in that area. Clustered 
cells were defined as the number of cells of 
one population localized together without the 
disruption of cells from the second population, 
here RFP-expressing cells. 
Live cells, BSC1 AP2-σ-EGFP63, were imaged 
at 37°C and 5% CO2 in a Perkin Elmer spinning 
disc microscope equipped with a 60x objective 
(Plan Apochromat VC, 1.4 NA, Nikon). Time-
lapse movies were collected at 2 s intervals for 
10 min with a cooled EMCCD camera 
(9100/02, Hamamatsu). Quantitation of EGFP-
AP2 lifetimes was performed with Volocity 
software by generating kymographs. Randomly 
selected events were used in the analysis. In 
the case where the fluorescent punctae existed 
in both the first and last frame it was included in 
the analysis, otherwise only events that 
appeared and disappeared within the movie 
were analyzed. A minimum of 700 events were 
analyzed per group. 
 
Transmission electron microscopy 
HeLa cells were pelleted and fixed in 2.5% (v/v) 
glutaraldehyde, 2% (v/v) paraformaldehyde, 
2% (w/v) tannic acid in phosphate buffered 
saline (pH 7.4), and then post-fixed in 1% 
osmiumtetraoxide in 0.1M cacaodylic acid (pH 
7.4). The samples were dehydrated in a graded 
series of ethanol during which they were 
stained en bloc with 1% uranyl acetate in 70% 
ethanol, and then embedded in Durcupan resin 
(Fluka). Serial ultrathin sections (70 nm) were 
cut with a diamond knife (Diatome) on a Leica 
UltraCutE ultratome. The sections were 
collected on formvar-coated copper grids, 
stained with 2% (w/v) uranylacetate in water 
and Reynold’s lead citrate, and viewed in a 
Tecnai G2 Spirit BioTWIN transmission 
electron microscope (FEI) equipped with a 
Gatan Orius 200BC CCD camera. 
 
Internalisation of transferrin 
HeLa cells and BSC1 cells were serum starved 
for 2h prior to ligand uptake, incubated with 
10µg/ml transferrin-Alexa546 (Life 
Technologies) for 5 min, washed twice with 
phosphate buffered saline pH 7.4 (PBS), and 
acid washed briefly to strip off surface-bound 
ligand (0.1M sodium acetate pH 4.6, 150mM 
NaCl, 2mM CaCl2). The cells were detached 
with trypsin, pelleted and fixed in 4% 
paraformaldehyde in PBS at 4°C for 10 min, 
pelleted and resuspended in PBS. Internalised 
fluorescent transferrin was quantified on a 
LSRFortessa cell analyzer (BD Biosciences). 
 
Statistical analysis 
For microscopy-based experiments where 
multiple experiments were analysed the 
number of images for each sample were 
chosen to provide statistically significant data 
for each sample (20-50 images). For pairwise 
comparisons where the samples had a normal 
distribution an unpaired two-sided t-test was 
used, while samples where the data was not 
normally distributed was analysed using the 
Mann-Whitney test. All statistical analysis was 
done using GraphPad Prism software. 
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Figure Legends 
Figure 1. Trans-endocytosis of EphB2/ephrinB1 is clathrin- and dynamin-dependent. 
A, Fluorescent images of co-cultures of Co115 cells stably expressing EphB2 (EGFP), ephrinB1 (RFP), 
EGFP or RFP. RFP has been pseudocoloured in magenta for visualisation purposes. Co-culture of 
EphB2 (EGFP) and ephrinB1 (RFP) expressing cells resulted in repulsion and clustering of the 
respective cell lines in a pattern, while the controls showed random cell mixing. Scale bar, 500µm.  B, 
Cell mixing was quantified by counting the percentage of EGFP-positive cells forming clusters of various 
sizes. In the absence of ephrinB1-expressing cells the majority of cells are found in clusters containing 
<10 cells. Co-cultures of EphB2 and ephrinB1 Co115 cell lines showed a large proportion of cells in 
homogenous clusters >30 cells. Error bars represent standard deviation (n = 5 random fields per 
condition). The frequency of cells in small clusters (<10 cells) is a representation of cell mixing and there 
is a significant difference between EphB2 co-cultured with ephrinB1 and RFP, and control EGFP plus 
RFP co-cultures (****p<0.0001, Student’s two-tailed unpaired t-test).	  C, The EphB-mediated patterning 
was analysed across random field of co-cultured EphB2- and ephrinB1-expressing cells. The pattern 
score takes into account random variation of the proportion of the EGFP- and RFP-expressing cells. 
Data represent mean ± standard error of the mean. ****p<0.0001, Student’s two-tailed unpaired t-test, 
n=20 per condition in four independent experiments.  D, Endocytosis was inhibited by expression of two 
reagents that have established dominant negative impact on endocytosis, dynamin1-T65A and AP180 
C-terminus and the effect on EphB2-mediated cell repulsion in the Co115 co-cultures was evaluated. 
Scale bar, 500µm. E, Cell mixing was quantified by counting the percentage of EGFP-positive cells 
forming clusters of various sizes in co-cultures of EphB2- and ephrinB1-expressing cells. In the control 
experiment a large proportion of cells were found in large (>30 cells) clusters, but this was dramatically 
reduced when clathrin-mediated endocytosis was inhibited by either expression of dynamin1-T65A or 
AP180 C-terminus. Error bars represent standard deviation (n = 5 random fields per condition, 
****p<0.0001, Student’s two-tailed unpaired t-test). F, Bar graph showing the quantification of EphB2-
mediated patterning of EphB2/ephrinB1 or control EphB2/RFP co-cultures expressing control BFP, 
dynamin1-T65A, or AP180 C-terminus. Data represent mean ± standard error of the mean. 
****p<0.0001, Student’s two-tailed unpaired t-test, at least 20 images were analysed in three 
independent experiments. 
 
Figure 2. EphB2 interacts with Numb and Eps15R. 
A, A limited screen for Numb interaction with individual EH domains from Eps15R, Eps15, intersectin-1, 
and intersectin-2. GST-tagged EH domains were used in a pull-down assay with lysates from EGFP-
Numb expressing HEK293T cells and analysed by Western blot. A Coomassie stained SDS-PAGE gels 
shows the equal loading of the EH domains. GST alone was used as a control.  B, Co-
immunoprecipitation analysis from HEK293T cells expressing Flag-EphB2, EGFP-Numb, and myc-
Eps15R. A kinase dead (KD) EphB2 mutant was used as a control. The cells were stimulated with pre-
clustered soluble ephrinB1 ligand. A Flag antibody was used for immunoprecipitation and co-
immunoprecipitation was assessed by Western blot. 
 
Figure 3. Eps15R regulates clathrin-mediated endocytosis. 
A, Live cell imaging of BSC1 cells stably expressing AP2-σ2-EGFP. Kymographs (10 minutes) from 
cells treated with control shRNA, shEPS15R, shEPS15 or shEPS15R+shEPS15 prior to imaging are 
shown. B, Quantification of AP2-σ2-EGFP lifetime on the plasma membrane in BSC1 cells. ***p<0.001, 
**p<0.01 Student’s two-tailed unpaired test, n=3 independent experiments. Mean ± standard error of 
mean. C, Western blot analysis of BSC1 cell lysates to assess Eps15R and Eps15 knockdown 
efficiency. D, Uptake of Alexa-546-transferrin in HeLa and BSC1 cells treated with control shRNA or 
shEPS15R, measured in a FACS analyser. ****p<0.0001; Student’s two-tailed unpaired test; n=30,000 
(HeLa), n=5,000 (BSC1). Data were normalised to shCTRL cells and given as mean ± standard error of 
the mean. E, Endogenous AP2 staining in HeLa cells treated with control or EPS15R shRNA (shCTRL, 
shEPS15R). Scale bar 10 µm. F, Bar graph showing quantification of the density of AP2 punctae in 
control and Eps15R knockdown HeLa cells shown in D. ****p<0.0001; two-tailed unpaired Student’s t-
test, n=70. Data represent mean ± standard deviation. G, Western blot showing the level of knockdown 
of endogenous Eps15R in HeLa cell lysate. H, Diameter of clathrin-coated structures (****p<0.0001; 
two-tailed unpaired Student’s t-test, n=200). Mean ± standard deviation. I, Diameter of clathrin-coated 
structures (****p<0.0001; two-tailed unpaired Student’s t-test, n=200). Mean ± standard deviation. J, 
Histogram showing the distribution of CCP neck width, n = 200.  K, Histogram showing the distribution 
of CCP neck from a subset of the data set with a neck width of 0-100 nm. L, Quantification of the CCP 
neck width presented in a box and whiskers plot (****p<0.0001; Mann-Whitney test, n=200). 
 
Figure 4. Eps15R interacts directly with clathrin heavy chain terminal domain. 
A, The interaction between Eps15R and clathrin were analysed in a co-immunoprecipitation assay 
where EGFP-Eps15R was immunoprecipitated from HeLa cell extract. EGFP and EGFP-Eps15 were 
used as controls. The samples were immunoblotted for clathrin, AP2 β-adaptin, and EGFP. B, 
Immunoprecipitation of C-terminally truncated EGFP-Eps15R constructs expressed in HeLa cells 
identified the motif domain (aa 596-747) as the clathrin-binding region.  Deletion of the UIM domains (aa 
	   15	  
1-861) or the proline-rich region (aa 1-747) did not affect clathrin binding. The samples were analysed 
by immunoblotting for clathrin, AP2-β-adaptin, and EGFP. C, The interaction between clathrin and the 
Eps15R motif domain (aa 558-747) was analysed by GST pull-downs. GST-tagged deletion constructs 
of the motif domain showed that the minimal peptide that bound clathrin was aa 717-729. D, GST pull-
down assay using alanine scanning mutations of the Eps15R clathrin-binding region (aa 717-729) 
identified a novel clathrin-binding motif, DPFxxLDPF. GST-fusion proteins were incubated with 
detergent extracts from HeLa cells and immunoblotted with antibodies against clathrin and AP2-β-
adaptin. E, Sequence alignment of Eps15R aa 699–729 (mouse) from different species showed that the 
DPFxxLDPF (aa 720-728) motif is conserved in vertebrates. The sequence annotation refers to the 
mouse protein sequence. In addition, it highlighted an additional LDPF motif (L700) that was conserved 
in mammals. Chimpanzee (Pan troglodytes), horse (Equus caballus), dog (Canis lupus familiaris), 
mouse (Mus muscularis), rat (Rattus Norvegicus), opossum (Monodelphis domestica), bat (Myotis 
brandtii), chicken (Gallus gallus), turtle (Chrysemys picta bellii), frog (Xenopus laevis), coelacanth 
(Latimera chalumnae), zebrafish (Danio rerio). F, The clathrin binding to Eps15R (aa 699-729) and 
Eps15 (aa 687-723) motif domains was compared in a GST pull-down assay. The asterisks point to the 
GST-tagged motif domain, and the band below in the lane is GST alone. G, Site-directed mutagenesis 
of amino acids F703, F722, F723 reduced the binding of clathrin to GST-Eps15R aa 699-729 from HeLa 
lysate in a GST pull-down assay. Samples were analysed by immunoblotting for clathrin and AP2. H, 
GST pull-down using Eps15R aa 701-747 and mutants of a DPF motif. Samples were analysed by 
immunoblotting for clathrin and AP2 I, The interactions between GST-clathrin heavy chain and 
recombinant full-length Eps15R were analysed in a GST pull-down assay. GST fusion proteins 
comprising the clathrin terminal domain (aa 2-579), distal domain (aa 438-1073), and proximal domain 
(aa 1073-1675) were incubated with detergent extracts of Sf9 cells expressing full-length His-Eps15R. 
Samples were analysed by immunoblotting for His-tagged Eps15R.  
 
Figure 5. Eps15R regulates AP2-clathrin complex formation in vitro and in vivo. 
A, Immuoprecipitates from HeLa lysates of EGFP-Eps15R wild type (wt) or mutant (mut; 
F703A/F722A/F728A) were analysed by immunoblotting for clathrin, AP2 β-adaptin, and EGFP to 
ensure equal loading. B, Quantification of Western blots from three independent experiments described 
in A. Mean ± standard error of the mean. **p<0.01, Student’s two-tailed unpaired t-test. C, A GST pull-
down assay using AP2-β-appendage with hinge, a construct that binds clathrin (aa 616-937;36). Lysates 
from HeLa cells expressing EGFP-Eps15R wild type (wt) or clathrin-binding mutant (F703A, F722A, 
F728A) were used. Samples were analysed with clathrin and EGFP immunoblotting. D, Bar graph 
showing the quantification of three independent experiments described in C. Data represent mean ± 
standard error of the mean. *p<0.05, Student’s two-tailed unpaired t-test. E, Immunofluorescence 
images of wild type EGFP-Eps15R, mutant EGFP-Eps15R (F703A, F722A, F728A) and endogenous 
AP2 and clathrin stain in HeLa cells. Scale bar 1µm. F, Bar graph showing the quantification of wild type 
and mutant EGFP-Eps15R fluorescent punctae (shown in E, G) in five independent experiments. Data 
represent mean ± standard error of the mean. ***p<0.0001, Student’s two-tailed unpaired test, n = 50.  
 
Figure 6. The role of Eps15R in EphB2 trans-endocytosis. 
A, Co-culture of Co115 cells stably expressing EphB2 (EGFP) or ephrinB1 (RFP). RFP has been 
pseudocoloured in magenta for visualisation purposes. Cells expressing EphB2 (EGFP) were treated 
with shRNA prior to co-culture. Scale bar, 500 µm. B, Bar graph showing the mean pattern score for 
EphB2/ephrinB1 co-cultures (dark blue). Control EGFP/RFP co-cultures of Co115 cells that do not 
express EphB receptor and ligand show random mixing of cells (light blue). Data represent mean ± 
standard error of the mean. ****p<0.0001, Student’s two-tailed unpaired t-test, n>20 in four independent 
experiments. C, Epifluorescence images of EphB2-ephrinB1 co-cultures where EphB2-expressing cells 
were treated with either shEPS15R or control shRNA. To rescue of the patterning defect as a result of 
Eps15R knockdown myc-Eps15R, myc-Eps15R mutant (F703A, F722A, F728A), myc-Eps15 or control 
BFP was expressed. Scale bar, 500µm. D, Quantification of patterning as a result of cell repulsion in co-
cultures of Co115 cells expressing EphB2 and ephrinB1. Data represent mean ± standard error of the 
mean. ****p<0.0001, Student’s two-tailed unpaired t-test, n>20 in four independent experiments. 
 
 
 
Supplementary Figure 1. Sequence alignment showing the conservation across species of the 
clathrin-binding motifs in Eps15R orthologues. 
Alignment of Eps15R orthologues showing conservation of various DPF motifs amongst 
vertebrates.  The numbering of residues in the consensus corresponds to positions within the human 
Eps15R sequence. 
 
Supplementary Figure 2. Eps15R clathrin-binding mutants are not mistargeted in cells. 
Confocal images of HeLa cells expressing wild type EGFP-Eps15R (A), EGFP-Eps15R-F703A (B), 
EGFP-Eps15R-F722A (C), EGFP-Eps15R-F728A (D), and endogenous immunostain of clathrin.  Scale 
bar, 10 µm.  E, Bar graph showing the mean size of EGFP-Eps15R wild type and mutant punctae 
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shown in panels A-D. Mean ± standard error of the mean, n = 15 images. Student’s two-tailed unpaired 
t-test. 
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